Years of extensive testing must be performed on any potential new treatment prior to being approved for use in the clinical to treat patients. The Privette Vinnedge laboratory conducts pre-clinical studies of new breast cancer treatments to determine their efficacy and feasibility for future use in clinical trials. We collaborate with Nicolas Nassar, JooYoup Lee, and other investigators to test nanoparticles and small molecules as potential new breast cancer therapies.